Oct 20, 2010 | Laboratory News, Laboratory Pathology
Company will develop solutions for new reimbursement models, evidence-based care, and supporting health service delivery needs Earlier this fall, IBM Corporation (NYSE: IBM) announced plans to invest $100 million specifically to advance IBM capabilities in three key areas of healthcare informatics. That seemed like a big deal that might affect clinical pathology, since IBM is one of the information technology (IT) giants in the United States. However, Dark Daily editors made a surprising...
